CELU - Celularity Inc - Ordinary Shares - Class A
Previous close
2.988
0 0%
Share volume: 6,230
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.99
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-16 | 2022-08-09 | 2022-11-10 | 2023-03-31 | 2023-05-22 | 2023-08-14 | 2024-01-03 | 2024-07-30 | |
| Assets | |||||||||
| Total Assets | 434.202 M | 429.337 M | 437.116 M | 401.066 M | 362.416 M | 246.419 M | 157.192 M | 143.889 M | |
| Current Assets | 75.739 M | 75.453 M | 63.097 M | 33.502 M | 25.004 M | 18.037 M | 16.498 M | 19.793 M | |
| Inventories | 14.715 M | 24.663 M | 5.239 M | 5.308 M | 5.484 M | 5.738 M | 4.934 M | 5.753 M | |
| Other Current Assets | 9.363 M | 8.861 M | 10.757 M | 9.776 M | 7.938 M | 6.403 M | 7.177 M | 3.767 M | |
| Short Term Investments | 9.363 M | 8.861 M | 10.757 M | 9.776 M | 7.938 M | 6.403 M | 7.177 M | 3.767 M | |
| Total Receivables | 3.622 M | 3.933 M | 4.452 M | 4.452 M | 3.050 M | 2.812 M | 4.114 M | 10.046 M | |
| Current Cash | 48.039 M | 37.996 M | 42.649 M | 13.966 M | 8.532 M | 3.084 M | 273.000 K | 227.000 K | |
| Total Non-current Assets | 358.463 M | 353.884 M | 374.019 M | 367.564 M | 337.412 M | 228.382 M | 140.694 M | 124.096 M | |
| Property Plant Equipment | 77.962 M | 77.540 M | 77.032 M | 75.655 M | 74.056 M | 72.624 M | 70.647 M | 67.828 M | |
| Other Assets | 19.726 M | 16.111 M | 37.304 M | 36.385 M | 38.017 M | 38.765 M | 36.321 M | 27.984 M | |
| Intangible Assets | 122.646 M | 122.100 M | 121.547 M | 120.994 M | 120.453 M | 12.107 M | 11.554 M | 11.001 M | |
| Goodwill | 123.304 M | 123.304 M | 123.304 M | 119.694 M | 90.061 M | 90.061 M | 7.347 M | 7.347 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 434.202 M | 429.337 M | 437.116 M | 401.066 M | 362.416 M | 246.419 M | 157.192 M | 143.889 M | |
| Total liabilities | 344.297 M | 279.187 M | 272.881 M | 202.165 M | 206.788 M | 127.918 M | 126.945 M | 102.929 M | |
| Total current liabilities | 26.034 M | 32.939 M | 69.219 M | 62.088 M | 66.458 M | 64.976 M | 84.632 M | 67.298 M | |
| Accounts Payable | 10.418 M | 10.226 M | 9.216 M | 5.810 M | 8.755 M | 12.448 M | 12.931 M | 14.144 M | |
| Other liabilities | 287.790 M | 218.388 M | 175.735 M | 112.083 M | 107.527 M | 17.804 M | 16.230 M | 9.445 M | |
| Current long term debt | 0.000 | 0.000 | 39.255 M | 37.603 M | 30.945 M | 16.816 M | 35.004 M | 39.240 M | |
| Long term debt | 30.463 M | 27.850 M | 27.917 M | 27.985 M | 32.794 M | 45.129 M | 26.074 M | 26.177 M | |
| Other liabilities | 287.790 M | 218.388 M | 175.735 M | 112.083 M | 107.527 M | 17.804 M | 16.230 M | 9.445 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 89.905 M | 150.150 M | 164.235 M | 198.901 M | 155.628 M | 118.501 M | 30.247 M | 40.960 M | |
| Common stock | 130.399 M | 140.152 M | 142.677 M | 146.400 M | 155.365 M | 176.564 M | 188.317 M | -44.899 M | |
| Retained earnings | -722.552 M | -674.729 M | -669.930 M | -645.496 M | -709.513 M | -757.462 M | -851.338 M | -841.791 M |